Evidence-Based Pediatric Oncology Evidence-Based Medicine
- 2nd edition
- Oxford: John Wiley & Sons, c2008
- 576 pages
Using the available systematic reviews and Standard OptionsRecommendations (SORs) which are evidence-based treatmentrecommendations, Evidence-based Pediatric Oncology is aground breaking text on the management of childhood cancers.Covering all tumour types occuring in children and young adults, itprovides systematic reviews with recommendations for optimumtreatments for childhood cancer.
Offering reviews and commentaries from leading internationallyrecognised paediatric oncologists, this fully revised secondedition now covers significant randomised controlled trails.
1405181427 9781405181426
= 6-mercaptopurine actinomycin acute lymphoblastic leukemia acute myeloid leukemia American Society analysis ARA-C asparaginase bone marrow cell chemotherapy childhood acute Children’s Cancer Group cisplatin Clin Oncol Clinical Oncology full CNS prophylaxis compared complete remission consolidation cranial irradiation cycles cyclophosphamide cytarabine daunorubicin Details dexamethasone diagnosis disease domized doxorubicin duration eligible patients etoposide evaluate Ewing’s excluded Figure GCSF GCSF group given GMCSF groups of patients high dose high risk ifosfamide included induction therapy infusion intravenous lymphoma maintenance therapy median medulloblastoma metastases methotrexate mg/m2 days neutropenia number of patients Objectives The aim Oncology full reference oral Outcome measures overall survival patients randomized patients received patients were randomized pegaspargase phase platelet prednisolone prednisone protocol radiation radiotherapy randomized to receive regimen risk group sarcoma Society of Clinical stage Study design surgery Table thioguanine toxicity transfusions treated treatment tumor versus vincristine weeks
--Neoplasms.-- Child. --Evidence-Based Medicine.--Medical / Oncology / General-- Medical / General -- Medical › Oncology › General